[Video] Episode 447 — Veloxis Pharmaceuticals’ $46 Million Kickback Settlement and What the CEP Really Rewards

In this episode of Corruption, Crime and Compliance, Michael Volkov breaks down Veloxis Pharmaceuticals’ more than $46 million settlement with DOJ and HHS-OIG over a years-long kickback scheme involving its kidney transplant drug Envarsus XR, a scheme the DPA says was directed in part by the company’s own former CEO. He examines why Veloxis avoided prosecution and instead secured a deferred prosecution agreement under DOJ’s Corporate Enforcement and Voluntary Self-Disclosure Policy despite…
By: The Volkov Law Group